24.2 C
New York
Thursday, June 11, 2026

Tag: emergencies

1-Hour Payday Loans with No Credit Check And Guaranteed Approval – Brand New Feature in Wizzay’s Loan Program in 2025

New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) --

Facing urgent expenses with limited credit options? Wizzay has introduced a fast-track solution: 1-hour payday loans with no hard credit check, instant decisions, and same-day funding in many cases. It’s designed for those who need cash instantly— not in days or weeks.

Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants

MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of (i) 31,500,000 of its common shares (the “Shares”), accompanying Series A common warrants (the “Series A Common Warrants”) to purchase an aggregate of 31,500,000 common shares and accompanying Series B common warrants (the “Series B Common Warrants”) to purchase an aggregate of 31,500,000 common shares , at a combined public offering price of $1.50 per share and accompanying Series A Common Warrant and Series B Common Warrant and (ii) in lieu of common shares to certain investors that so choose, pre-funded warrants to purchase 3,502,335 common shares, accompanying Series A Common Warrants to purchase an aggregate of 3,502,335 common shares and accompanying Series B Common Warrants to purchase an aggregate of 3,502,335 common shares, at a combined public offering price of $1.499 per pre-funded warrant and accompanying Series A Common Warrant and Series B Common Warrant, which represents the combined public offering price for the Shares and accompanying common warrants less the $0.001 per share exercise price for each such pre-funded warrant. The proceeds to Milestone from the Offering, before deducting underwriting commissions and offering expenses payable by Milestone, are expected to be approximately $52.5 million. The Offering is expected to close on or about July 14, 2025, subject to satisfaction of customary closing conditions.

Milestone Pharmaceuticals Announces Proposed Public Offering

MONTREAL, Quebec and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST) today announced that it has commenced an underwritten public offering (the “Offering”) of its common shares, accompanying Series A warrants to purchase common shares (the “Series A Warrants”) and accompanying Series B warrants to purchase common shares (the “Series B Warrants”), and, in lieu of common shares to certain investors that so choose, pre-funded warrants to purchase common shares, accompanying Series A Warrants and accompanying Series B warrants. All securities to be sold in the Offering will be sold by Milestone. The Offering is subject to market and other conditions and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Find Georgia’s hidden gems for summer recreation at Georgia Power’s lakes and campgrounds

Company highlights "SPLASH" guidelines and electrical tips for safer summer funCampground reservation system makes booking sites easier ATLANTA, July 9, 2025 /PRNewswire/ -- With the...

Brunswick Corporation Schedules 2025 Second Quarter Earnings Conference Call

METTAWA, Ill., July 09, 2025 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2025 second quarter financial results on Thursday, July 24, 2025 before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website at https://ir.brunswick.com.  The results will also be available on the SEC’s website with the Form 8-K filing of the release at http://goo.gl/wJQN1.   

CENTEGIX® Platform Partner Program Surges to 80 Partners Driving Accelerated Emergency Response and Increased ROI on Safety Investments

Program connects trusted safety technologies into the CENTEGIX Safety Platform™, delivering more value from existing systems and enabling faster, coordinated response ATLANTA, July 9, 2025...

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.

ICE Box System Surges in Popularity as 2025 Families Seek Secure, At-Home Legacy Planning Solutions

Rising search trends for “fireproof document safe,” “estate planning organizer,” and “emergency binder kit” spotlight ICE Box System as a non-digital solution for families protecting vital records and valuables at home.
Rising search trends for “fireproof document safe,” “estate planning organizer,” and “emergency binder kit” spotlight ICE Box System as a non-digital solution for families protecting vital records and valuables at home.

Every second counts: Augmented reality tool helps train Canadians for home fire emergencies

Kidde's “Prepare. Plan. Practice.”, a first-of-its-kind digital simulator, brings fire safety training into the home — no downloads required.

Valeura Energy Inc.: Q2 2025 Operations and Financial Update

SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) is pleased to provide an update on Q2 2025 operations.

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/...

Propane Council of Texas Offers Key Safety Reminders After Recent Flooding

AUSTIN, Texas , July 6, 2025 /PRNewswire/ -- In the wake of historic flooding that has inundated neighborhoods across Texas—dropping more than a foot of rain...

No Denial Payday Loans – Direct Lenders for Instant Cash in 2025

Explore Fast-Approval Payday Loans from Trusted Direct Lenders—Flexible Options Available in 2025
Explore Fast-Approval Payday Loans from Trusted Direct Lenders—Flexible Options Available in 2025

US Online Payday Loans Guaranteed Approval No Credit Check – RadCred’s Instant Loan Solutions for U.S. Borrowers

RadCred offers online payday loans with guaranteed approval for U.S. borrowers. Fast funding, no credit check, and flexible loan options for urgent needs.
RadCred offers online payday loans with guaranteed approval for U.S. borrowers. Fast funding, no credit check, and flexible loan options for urgent needs.

- A word from our sponsors -

spot_img
HomeTagsEmergencies